National Health Act 1953 Amendment Determinations under sections 85, 85A and 88 pharmaceutical benefits (No. PB 51 of 2008) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 51 of 2008
Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.
Dated 1st May 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — pharmaceutical benefits
1 Commencement
This instrument commences on 1 June 2008.
2 Amendment of PB 89 of 2007
Schedule 1 amends PB 89 of 2007.
Schedule 1 Amendments
Part 1 of Schedule 1, item dealing with Captopril in the forms Tablet 12.5 mg, Tablet 25 mg and Tablet 50 mg
omit from the column headed “Brand”:
Genepharm Limited
and substitute:
Genepharm Pty Ltd
Part 1 of Schedule 1, item dealing with Ciprofloxacin in the forms Tablet 500 mg (as hydrochloride) and
Tablet 750 mg (as hydrochloride)
omit from the column headed “Brand”:
Genepharm Australasia Limited
and substitute:
Genepharm Pty Ltd
[3] Part 1 of Schedule 1, item dealing with Citalopram in the form Tablet 20 mg (as hydrobromide)
(a) in the column headed “Brand” insert in alphabetical order:
Celica
(b) omit from the column headed “Brand”:
Citalopram-RL
[4] Part 1 of Schedule 1, item dealing with Codeine with Paracetamol in the form Tablet containing codeine phosphate 30 mg with paracetamol 500 mg
omit from the column headed “Brand”:
Dymadon Forte
[5] Part 1 of Schedule 1, after item dealing with Drotrecogin Alfa (activated)
insert in the columns in the order indicated:
| Duloxetine | Capsule 30 mg (as hydrochloride) Capsule 60 mg (as hydrochloride) | Oral Oral | 28 28 | .. 5 | Cymbalta Cymbalta |
[6] Part 1 of Schedule 1, item dealing with Felodipine in the form Tablet 5 mg (extended release)
omit from the column headed “Brand”:
Felodipine XR 5
and substitute:
Felodil XR 5
[7] Part 1 of Schedule 1, item dealing with Felodipine in the form Tablet 10 mg (extended release)
omit from the column headed “Brand”:
Felodipine XR 10
and substitute:
Felodil XR 10
[8] Part 1 of Schedule 1, item dealing with Flucloxacillin
omit from the columns in the order indicated:
| Powder for oral suspension 125 mg (as magnesium) per 5 mL, 100 mL | Oral | 1 | .. | Floxapen |
[9] Part 1 of Schedule 1, item dealing with Gabapentin in the form Tablet 600 mg
omit from the column headed “Brand”:
Pharmacor Gabapentin 600
[10] Part 1 of Schedule 1, item dealing with Gabapentin in the form Tablet 800 mg
omit from the column headed “Brand”:
Pharmacor Gabapentin 800
[11] Part 1 of Schedule 1, after item dealing with Glucose Indicator—Blood in the form Electrode strips, 50 (TrueTrack)
insert in the columns in the order indicated:
| Electrode strips, 100 (FreeStyle Lite) | For external use | 1 | 5 | FreeStyle Lite |
[12] Part 1 of Schedule 1, item dealing with Hydrochlorothiazide with Amiloride
omit from the column headed “Brand”:
Amizide
[13] Part 1 of Schedule 1, item dealing with Meloxicam in the form Tablet 7.5 mg
in the column headed “Brand” insert in alphabetical order:
Meloxicam Winthrop
[14] Part 1 of Schedule 1, item dealing with Meloxicam in the form Tablet 15 mg
in the column headed “Brand” insert in alphabetical order:
Meloxicam Winthrop
[15] Part 1 of Schedule 1, item dealing with Metformin in the forms Tablet containing metformin hydrochloride 500 mg and Tablet containing metformin hydrochloride 850 mg
omit from the column headed “Brand”:
Genepharm Australasia Limited
and substitute:
Genepharm Pty Ltd
[16] Part 1 of Schedule 1, item dealing with Norfloxacin
omit from the column headed “Brand”:
Genepharm Limited
and substitute:
Genepharm Pty Ltd
[17] Part 1 of Schedule 1, item dealing with Oxaliplatin in the form Powder for I.V. infusion 50 mg
omit from the column headed “Brand”:
Oxaliplan 50
[18] Part 1 of Schedule 1, item dealing with Oxaliplatin in the form Powder for I.V. infusion 100 mg
omit from the column headed “Brand”:
Oxaliplan 100
[19] Part 1 of Schedule 1, after item dealing with Potassium Chloride with Potassium Bicarbonate
insert in the columns in the order indicated:
| Pramipexole | Tablet containing pramipexole hydrochloride Tablet containing pramipexole hydrochloride Tablet containing pramipexole hydrochloride 1 mg | Oral Oral Oral | 30 100 100 | .. 5 5 | Sifrol Sifrol Sifrol |
[20] Part 1 of Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 10 mg
omit from the column headed “Brand”:
Pravastatin-RL
[21] Part 1 of Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 20 mg
omit from the column headed “Brand”:
Pravastatin-RL
[22] Part 1 of Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 40 mg
omit from the column headed “Brand”:
Pravastatin-RL
[23] Part 1 of Schedule 1, item dealing with Quinapril in the form Tablet 20 mg (as hydrochloride)
in the column headed “Brand” insert in alphabetical order:
Quinapril Sandoz
[24] Part 1 of Schedule 1, item dealing with Roxithromycin in the form Tablet 150 mg
omit from the column headed “Brand”:
Roxithromycin-RL
[25] Part 1 of Schedule 1, item dealing with Roxithromycin in the form Tablet 300 mg
omit from the column headed “Brand”:
Roxithromycin-RL
[26] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 5 mg
omit from the column headed “Brand”:
Simvastatin-RL
[27] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 10 mg
(a) omit from the column headed “Brand”:
Genepharm Australasia Limited
and substitute:
Genepharm Pty Ltd
(b) omit from the column headed “Brand”:
Simvastatin-RL
[28] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 20 mg
(a) omit from the column headed “Brand”:
Genepharm Australasia Limited
and substitute:
Genepharm Pty Ltd
(b) omit from the column headed “Brand”:
Simvastatin-RL
[29] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 40 mg
(a) omit from the column headed “Brand”:
Genepharm Australasia Limited
and substitute:
Genepharm Pty Ltd
(b) omit from the column headed “Brand”:
Simvastatin-RL
[30] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 80 mg
(a) omit from the column headed “Brand”:
Genepharm Australasia Limited
and substitute:
Genepharm Pty Ltd
(b) omit from the column headed “Brand”:
Simvastatin-RL
[31] Part 2 of Schedule 1, item dealing with Codeine with Paracetamol in the form Tablet containing codeine phosphate 30 mg with paracetamol 500 mg
omit from the column headed “Brand”:
Dymadon Forte
[32] Part 1 of Schedule 3, item dealing with Codeine with Paracetamol in the form Tablet containing codeine phosphate 30 mg with paracetamol 500 mg
omit from the column headed “Brand”:
Dymadon Forte
[33] Part 1 of Schedule 3, item dealing with Flucloxacillin
omit from the columns in the order indicated:
| Powder for oral suspension 125 mg (as magnesium) per 5 mL, 100 mL | Oral | 1 | .. | Floxapen |
0
0
0